Top Markets
#1 Black Phoenix Black Phoenix +167.53%
#2 Islamic Coin Islamic Coin +158.30%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +29.49%
#5 Test Test +23.70%
#6 Cryptopia Cryptopia +20.92%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.38%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +17.98%
#9 Steem Steem +13.65%
#10 MarsCoin MarsCoin +9.72%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.

Sienna Biopharmaceuticals, Inc.

SNNAQ
Classement en actions #42234
Sienna Biopharmaceuticals, Inc. was a clinical-stage biopharmaceutical firm... Sienna Biopharmaceuticals, Inc. was a clinical-stage biopharmaceutical firm dedicated to discovering and advancing pharmaceutical treatments across diverse therapeutic fields. Its primary focus involved crafting therapies within immunology and inflammation, specifically targeting particular tissue pathways, notably in the skin. Among its pipeline, SNA-120 stood out as a pioneering, first-in-class inhibitor of tropomyosin receptor kinase A, undergoing Phase IIb clinical evaluation for addressing psoriasis and its associated itching. Another key candidate, SNA-125, a topical dual Janus kinase 3 inhibitor, progressed through Phase I/II clinical studies for conditions like atopic dermatitis, psoriasis, and pruritus. Furthermore, Sienna was advancing SNA-001, a topical suspension incorporating silver particles, into pivotal clinical trials not only for acne treatment but also for diminishing light-colored hair, encompassing shades such as white, gray, blonde, light brown, and light red. Established in 2010 and based in Westlake Village, California, the company originally operated as Sienna Labs, Inc. before rebranding as Sienna Biopharmaceuticals, Inc. in February 2016. However, the firm faced significant financial challenges, initiating Chapter 11 bankruptcy proceedings on September 16, 2019, which subsequently converted to Chapter 7 liquidation on December 18, 2019.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$3.09K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Sienna Biopharmaceuticals, Inc. (SNNAQ)

Catégorie

Healthcare
Le prix SNNAQ avec la capitalisation boursière de B
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.0001
Capitalisation boursière de Sienna Biopharmaceuticals, Inc.(SNNAQ)
Capitalisation boursière: $3.09K
En August 2026, Sienna Biopharmaceuticals, Inc. a une capitalisation boursière de $3.09K. Cela fait de Sienna Biopharmaceuticals, Inc. la 42234th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Sienna Biopharmaceuticals, Inc. du 2017 au 2026
SNNAQ par rapport au top 5 des plus populaires stocks
Prix pour SNNAQ L’actif B La capitalisation boursière de B Résultats
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$174,162 $3.09K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +174,162,389,417.96%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$143,106 $3.09K
Apple Inc. Apple Inc.
AAPL
$4.423T +143,105,506,329.57%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$134,596 $3.09K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +134,596,227,628.31%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$118,516 $3.09K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +118,515,717,693.59%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$93,537.00 $3.09K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +93,537,003,956.94%